SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by GSK Plc on July 22, 2022, for the month of July 2022. The filing serves as a notification of a major holding change pursuant to UK Disclosure and Transparency Rules (DTR), specifically triggered by a restatement of holdings following an ISIN change for the issuer's shares.
Key Financial Metrics
The filing text does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a regulatory notification regarding shareholder ownership percentages.
Material Changes
The primary material change reported is a reduction in the total voting rights held by BlackRock, Inc. due to a restatement following an ISIN update (from GB0009252882 to GB00BN7SWP63).
- Previous Total Position: 6.40% (6.34% shares + 0.06% financial instruments)
- Current Total Position: 5.69% (5.63% shares + 0.06% financial instruments)
- Threshold Date: July 19, 2022
- Total Voting Rights Held: 231,975,400
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a standard form notification (TR-1) detailing the chain of controlled undertakings through which BlackRock, Inc. holds its voting rights.
Investor Verification Checklist
- Verify the impact of the ISIN change (GB0009252882 to GB00BN7SWP63) on historical shareholding data.
- Confirm the breakdown of BlackRock's holding: 229,134,683 direct voting rights (5.63%) versus financial instruments (0.06%).
- Note that the reduction from 6.40% to 5.69% is attributed to the restatement of the holding rather than a disclosed sale of assets.
- Review the extensive list of controlled undertakings (Chains 1-14) to understand the corporate structure through which the voting rights are held.